4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-008923
Options or other derivatives
- President and CEO acquired 446,462 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2020-02-10 | Grant or award · Restricted Stock Units | +78,787 | 78,787 | D | ||
| Watts Ryan J. President and CEO | 2020-02-10 | Grant or award · Stock Option (right to buy) | +367,675 | 367,675 | D | ||
Loading xslF345X03/doc4.xml…